A detailed history of Adar1 Capital Management, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 3,000 shares of CELC stock, worth $39,870. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,000
Previous 1,400 114.29%
Holding current value
$39,870
Previous $22.9 Million 95.05%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $22,368 - $30,639
1,600 Added 114.29%
3,000 $44.7 Million
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $19,740 - $29,092
1,400 New
1,400 $22.9 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $199M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.